Novanta (NOVT) CFO equity grant, option exercises and planned stock sales
Rhea-AI Filing Summary
Novanta Inc.’s Chief Financial Officer Robert Buckley reported multiple equity transactions on common stock and equity awards. He received a grant of 11,990 Restricted Stock Units, each convertible into one common share upon vesting in three equal installments on February 20 of 2027, 2028, and 2029.
He also exercised derivative awards into common stock, including Restricted Stock Units and stock options that had previously vested, and had 93,814 common shares held directly afterward. To cover taxes, 1,185 shares were disposed of at about $145.96 per share, and additional open-market sales totaling 1,423 shares occurred around $140–$144 per share under a pre-established Rule 10b5-1 trading plan. Buckley also reported 36,219 common shares held indirectly through the Buckley Family Irrevocable Trust.
Positive
- None.
Negative
- None.
Insights
CFO received new RSUs and exercised awards while selling a small share amount.
Novanta’s CFO Robert Buckley was granted 11,990 Restricted Stock Units, with scheduled vesting through 2029. He also exercised previously vested RSUs and stock options into common stock, increasing his direct holdings before subsequent dispositions.
Disposals included 1,185 shares surrendered at about $145.96 per share for tax withholding and open-market sales totaling 1,423 shares around $140–$144. The sales were executed under a pre-established Rule 10b5-1 trading plan, indicating they were planned in advance rather than reactive. He continued to hold 93,814 shares directly and 36,219 shares indirectly via a family trust after these transactions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 11,990 | $0.00 | -- |
| Exercise | Restricted Stock Units | 2,450 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 1,423 | $0.00 | -- |
| Exercise | Common Stock | 2,450 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,185 | $145.96 | $173K |
| Exercise | Common Stock | 1,423 | $14.13 | $20K |
| Sale | Common Stock | 986 | $140.09 | $138K |
| Sale | Common Stock | 425 | $142.62 | $61K |
| Sale | Common Stock | 12 | $143.71 | $2K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit. The sales reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025. This transaction was executed in multiple trades ranging from $142.47 to $143.10. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The Restricted Stock Units vest in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029. The Restricted Stock Units vest in three equal installments on February 20, 2026, February 20, 2027 and February 20, 2028. The Stock Options vested in three equal installments on March 30, 2017, March 30, 2018, and March 30, 2019.
